In addition, it has been suggested that insulin resistance in pregnant women with GDM and their newborns may be due to decreased signals of protein kinase B/Akt (Akt) and mammalian target of rapamycin (mTOR) in human placental endothelial cells [130]. The gene discussed is MTOR; the disease is gestational diabetes.